The role of mechanistic target of rapamycin in maintenance of glomerular epithelial cells

被引:11
|
作者
Yao, Yao [1 ]
Inoki, Ken [1 ,2 ,3 ]
机构
[1] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
来源
基金
美国国家卫生研究院;
关键词
glomerular epithelial cells; mTOR; podocytes; rapamycin; renal diseases; P70; S6; KINASE; GTP-BINDING PROTEINS; RICTOR-MTOR COMPLEX; MOTIF PHOSPHORYLATION; DIABETIC-NEPHROPATHY; ACTIN CYTOSKELETON; MAMMALIAN TARGET; ANGIOTENSIN-II; RAG GTPASES; AMINO-ACIDS;
D O I
10.1097/MNH.0000000000000181
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewRecent studies have emerged to reveal the pivotal roles of mechanistic target of rapamycin (mTOR) signaling not only in the maintenance of the physiological functions of renal cells but also in the pathogenesis of renal cell dysfunctions and kidney diseases. We introduce the current understanding of mTOR signaling, and its crucial roles in glomerular epithelial cell biology and the pathophysiology related to kidney diseases.Recent findingsmTOR, a Ser/Thr kinase, forms two distinct functional complexes, mTORC1 and mTORC2. Recent studies revealed that physiologic levels of mTORC1 and mTORC2 activity play key roles in maintaining podocyte and glomerular functions. However, aberrant activation of mTORC1or loss of mTORC2 activity in podocytes may underlie the pathogenesis of glomerular disorders, including diabetic kidney disease.SummaryAn effective treatment for mTORC1-associated podocyte and glomerular dysfunction may require the attenuation of mTORC1 activity in the setting of both an intact mTORC2 pathway and normal basal mTORC1 activity in order to preserve physiologic podocyte functions.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 50 条
  • [21] Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
    Querfurth, Henry
    Lee, Han-Kyu
    MOLECULAR NEURODEGENERATION, 2021, 16 (01)
  • [22] Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
    Andras Perl
    Nature Reviews Rheumatology, 2016, 12 : 169 - 182
  • [23] Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
    Perl, Andras
    NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (03) : 169 - 182
  • [24] Stem cell guidance through the mechanistic target of rapamycin
    Maiese, Kenneth
    WORLD JOURNAL OF STEM CELLS, 2015, 7 (07): : 999 - 1009
  • [25] Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
    Henry Querfurth
    Han-Kyu Lee
    Molecular Neurodegeneration, 16
  • [26] Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial Infarction
    Tardif, Jean-Claude
    Thorin, Eric
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (19) : 1815 - 1817
  • [27] Mechanistic target of rapamycin (mTOR) signaling in status epilepticus
    Crino, Peter B.
    EPILEPSY & BEHAVIOR, 2019, 101
  • [28] Mechanistic target of rapamycin(mTOR): Amediator of social development
    Ball, Gregory F.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (35) : 9240 - 9242
  • [29] The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond
    Lee, Peter L.
    Jung, Su Myung
    Guertin, David A.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2017, 28 (05): : 319 - 339
  • [30] Combination of histidine, lysine, methionine, and leucine promotes β-casein synthesis via the mechanistic target of rapamycin signaling pathway in bovine mammary epithelial cells
    Gao, H. N.
    Zhao, S. G.
    Zheng, N.
    Zhang, Y. D.
    Wang, S. S.
    Zhou, X. Q.
    Wang, J. Q.
    JOURNAL OF DAIRY SCIENCE, 2017, 100 (09) : 7696 - 7709